Loading…
MicroPort Medical (Hong Kong) and SRL (owned by Yunfeng Fund III) agreed to jointly fund the acquisition of LivaNova's CRM business for up to $200 million. MicroPort Hong Kong will hold 75% and SRL 25% of the buyer, MicroPort Cardiac Rhythm B.V.